Shanghai HeartCare Medical Technology Corporation Limited

SEHK:6609 Stock Report

Market Cap: HK$884.9m

Shanghai HeartCare Medical Technology Future Growth

Future criteria checks 3/6

Shanghai HeartCare Medical Technology is forecast to grow earnings and revenue by 111.8% and 1.8% per annum respectively while EPS is expected to grow by 188.3% per annum.

Key information

111.8%

Earnings growth rate

188.3%

EPS growth rate

Medical Equipment earnings growth41.3%
Revenue growth rate1.8%
Future return on equityn/a
Analyst coverage

Low

Last updated03 Sep 2024

Recent future growth updates

Recent updates

Even With A 42% Surge, Cautious Investors Are Not Rewarding Shanghai HeartCare Medical Technology Corporation Limited's (HKG:6609) Performance Completely

Sep 27
Even With A 42% Surge, Cautious Investors Are Not Rewarding Shanghai HeartCare Medical Technology Corporation Limited's (HKG:6609) Performance Completely

Some Shareholders Feeling Restless Over Shanghai HeartCare Medical Technology Corporation Limited's (HKG:6609) P/S Ratio

Aug 01
Some Shareholders Feeling Restless Over Shanghai HeartCare Medical Technology Corporation Limited's (HKG:6609) P/S Ratio

We're Not Very Worried About Shanghai HeartCare Medical Technology's (HKG:6609) Cash Burn Rate

Jan 23
We're Not Very Worried About Shanghai HeartCare Medical Technology's (HKG:6609) Cash Burn Rate

Shanghai HeartCare Medical Technology Corporation Limited (HKG:6609) Shares May Have Slumped 27% But Getting In Cheap Is Still Unlikely

Aug 30
Shanghai HeartCare Medical Technology Corporation Limited (HKG:6609) Shares May Have Slumped 27% But Getting In Cheap Is Still Unlikely

Companies Like Shanghai HeartCare Medical Technology (HKG:6609) Are In A Position To Invest In Growth

Aug 09
Companies Like Shanghai HeartCare Medical Technology (HKG:6609) Are In A Position To Invest In Growth

Companies Like Shanghai HeartCare Medical Technology (HKG:6609) Are In A Position To Invest In Growth

May 07
Companies Like Shanghai HeartCare Medical Technology (HKG:6609) Are In A Position To Invest In Growth

We're Hopeful That Shanghai HeartCare Medical Technology (HKG:6609) Will Use Its Cash Wisely

Nov 29
We're Hopeful That Shanghai HeartCare Medical Technology (HKG:6609) Will Use Its Cash Wisely

Earnings and Revenue Growth Forecasts

SEHK:6609 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202538737N/A-622
12/31/20242951N/A-192
6/30/2024251-4528-9N/A
3/31/2024242-69-34-49N/A
12/31/2023232-94-96-88N/A
9/30/2023224-141-176-142N/A
6/30/2023216-188-255-195N/A
3/31/2023199-194-280-231N/A
12/31/2022183-200-304-267N/A
9/30/2022160-185-318-272N/A
6/30/2022137-169-332-278N/A
3/31/2022115-188-298-243N/A
12/31/202190-194-260-206N/A
9/30/202166-242-216-169N/A
6/30/202143-290-171-133N/A
3/31/202128-244-129-102N/A
12/31/202015-214-90-75N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 6609 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.3%).

Earnings vs Market: 6609 is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: 6609 is expected to become profitable in the next 3 years.

Revenue vs Market: 6609's revenue (1.8% per year) is forecast to grow slower than the Hong Kong market (7.8% per year).

High Growth Revenue: 6609's revenue (1.8% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if 6609's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/19 10:18
End of Day Share Price 2024/12/19 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Shanghai HeartCare Medical Technology Corporation Limited is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jin ZhangChina International Capital Corporation Limited
Yuan GaoChina International Capital Corporation Limited
Chris PanGoldman Sachs